Monitoring of WT1-specific cytotoxic T-lymphocytes after allogeneic haematopoietic stem cell transplantation

被引：0
|
作者：
Morita, Y
Heike, Y
Kawakami, M
Miura, O
Mori, S
Tanosaki, R
Fukuda, T
Kim, S
Tobinai, K
Takaue, Y
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [31] Cerebral infections after allogeneic haematopoietic stem cell transplantation
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Keller, MT
    Schulte, C
    Hlinka, M
    Koldehoff, M
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2006, 37 : S168 - S168
  • [32] Haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation
    Al Sabty, F.
    Demeckova, E.
    Bojtarova, E.
    Czako, B.
    Hrubisko, M.
    Kubalova, S.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S84 - S84
  • [33] Erythropoietin in anaemias after allogeneic haematopoietic stem cell transplantation
    Stadler, M
    Reuter, C
    Varvenne, M
    Elser, C
    Kamal, H
    Eder, M
    Ganser, A
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S186 - S186
  • [34] Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides
    Fujiki, Fumihiro
    Tsuboi, Akihiro
    Morimoto, Soyoko
    Hashimoto, Naoya
    Inatome, Miki
    Nakajima, Hiroko
    Nakata, Jun
    Nishida, Sumiyuki
    Hasegawa, Kana
    Hosen, Naoki
    Oka, Yoshihiro
    Oji, Yusuke
    Sogo, Shinji
    Sugiyama, Haruo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 253 - 263
  • [35] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1191 - 1192
  • [36] Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides
    Fumihiro Fujiki
    Akihiro Tsuboi
    Soyoko Morimoto
    Naoya Hashimoto
    Miki Inatome
    Hiroko Nakajima
    Jun Nakata
    Sumiyuki Nishida
    Kana Hasegawa
    Naoki Hosen
    Yoshihiro Oka
    Yusuke Oji
    Shinji Sogo
    Haruo Sugiyama
    Cancer Immunology, Immunotherapy, 2021, 70 : 253 - 263
  • [37] LMP-specific cytotoxic T-lymphocytes administered to EBV plus lymphoma patients after stem cell transplant
    Bollard, C. M.
    Gottschalk, S.
    Sheehan, A.
    Mims, M.
    Carrum, G.
    Liu, H.
    Gee, A. P.
    Brenner, M. K.
    Rooney, C. M.
    Heslop, H. E.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S37 - S37
  • [38] Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Smallbone, Portia
    Louw, Alison
    Purtill, Duncan
    PATHOLOGY, 2024, 56 (01) : 24 - 32
  • [39] Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation
    Micklethwaite, Kenneth
    Hansen, Anna
    Foster, Aaron
    Snape, Elizabeth
    Antonenas, Vicki
    Sartar, Mary
    Shaw, Peter
    Bradstock, Ken
    Gottlieb, David
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (06) : 707 - 714
  • [40] Development of Novel Stem Cell Transplantation and Gene-Immunotherapy Using WT1-Specific T-Cell Receptor Gene.
    Ochi, Toshiki
    Fujiwara, Hiroshi
    Nagai, Kozo
    Shirakata, Toshiaki
    Kuzushima, Kiyotaka
    Okamoto, Sachiko
    Mineno, Junichi
    Shiku, Hiroshi
    Ozawa, Hidetoshi
    Ishikawa, Fumihiko
    Yasukawa, Masaki
    BLOOD, 2009, 114 (22) : 1180 - 1180
12345